Unicorn Nest Logo

Fuho Capital

fuhocapital.com
Status

Active

Total investments

25

Average round size

6M

Portfolio companies

22

Rounds per year

1.56

Lead investments

4

Follow on index

0.12

Exits

2

Areas of investment
BiotechnologyInformation TechnologyFood and BeverageFood ProcessingHealth CareManufacturingMedicalPharmaceuticalHardwareNetwork Hardware

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Find investors

Investments analytics

Analytics

Total investments
25
Lead investments
4
Exits
2
Rounds per year
1.56
Follow on index
0.12
Investments by industry
  • Health Care (6)
  • Pharmaceutical (6)
  • Manufacturing (5)
  • Medical (5)
  • Biotechnology (5)
    • Show 30 more
Investments by region
  • China (23)
  • Switzerland (1)
Peak activity year
2015

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
13
Group Appearance index
0.80
Avg. company exit year
63

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Leman Biotech 18 Jun 2024 Biotechnology, Health Care, Medical, Pharmaceutical Seed 7M Switzerland, Vaud, Lausanne
Stallion Synergies 04 Apr 2014 Market Research Seed 2K United States, New York, New York
TaiRui 14 Feb 2011 Health Care, Manufacturing, Medical Early Stage Venture 1M Ningxia, Xingqing, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.